Although HJURP has arisen as a potential biomarker for BC and a promising predictive indicator of sensitivity to tumor radiotherapy, further evaluation and validation of HJURP as a predictive marker for the diagnosis and prognosis of multimodal treatment of BC is clearly needed (Coates et al., 2010). This evidence concerns the gene HJURP and breast cancer.